Name | N-ribosylnicotinamide |
---|---|
Synonyms |
Pyridinium, 3-(aminocarbonyl)-1-β-D-ribofuranosyl-
Nicotinamide riboside-oxidized form 3-Carbamoyl-1-(β-D-ribofuranosyl)pyridinium Nicotinamide Ribose 3-(Aminocarbonyl)-1beta-D-ribofuranosylpyridinium 1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyridine-5-carboxamide NRH-oxidized form 3-(aminocarbonyl)-1-β-D-ribofuranosyl-Pyridinium Nicotinamide riboside N-ribosylnicotinamid |
Description | Nicotinamide riboside is a crystal form of Nicotinamide riboside (NR) chloride. Nicotinamide riboside increases NAD[+] levels and activates SIRT1 and SIRT3, culminating in enhanced oxidative metabolism and protection against high fat diet-induced metabolic abnormalities. Nicotinamide riboside is used in dietary supplements[1]. |
---|---|
Related Catalog | |
Target |
SIRT1 SIRT3 |
In Vitro | Nicotinamide riboside (0.5 nM; 24 hours) reduces the acetylation status of Ndufa9 and SOD2[1]. Western Blot Analysis[1] Cell Line: HEK293T cells Concentration: 0.5 nM Incubation Time: 24 hours Result: Reduced the acetylation status of Ndufa9 and SOD2. |
In Vivo | Chronic Nicotinamide riboside (p.o.; 400 mg/kg/day; for 16 weeks) supplementation increases plasma and intracellular NAD[+] content in a tissue-specific manner[1]. Animal Model: 10-week-old C57Bl/6J mice[1] Dosage: 400 mg/kg Administration: p.o.; daily; for 16 weeks Result: Increased plasma and intracellular NAD[+] content in a tissue-specific manner. |
References |
Density | 1.201g/cm3 |
---|---|
Boiling Point | 353.7ºC at 760mmHg |
Molecular Formula | C11H15N2O5 |
Molecular Weight | 255.247 |
Flash Point | 181.9ºC |
Exact Mass | 255.097549 |
PSA | 116.25000 |
LogP | -2.30 |
Vapour Pressure | 3.05E-07mmHg at 25°C |
Index of Refraction | 1.549 |
Hazard Codes | Xn |
---|
~% 1341-23-7 |
Literature: Angewandte Chemie - International Edition, , vol. 43, # 35 p. 4637 - 4640 |
Precursor 2 | |
---|---|
DownStream 1 | |